Premium
Molecular characterization of KMT2A fusion partner genes in 13 cases of pediatric leukemia with complex or cryptic karyotypes
Author(s) -
Ney Garcia Daniela R.,
Souza Mariana T.,
Figueiredo Amanda F.,
Othman Moneeb A. K.,
Rittscher Katharina,
Abdelhay Eliana,
Capela de Matos Roberto R.,
Meyer Claus,
Marschalek Rolf,
Land Marcelo G. P.,
Liehr Thomas,
Ribeiro Raul C.,
Silva Maria Luiza Macedo
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2299
Subject(s) - karyotype , chromosomal translocation , fusion gene , biology , breakpoint , genetics , myeloid leukemia , gene , exon , cancer research , chromosome
In pediatric acute leukemias, reciprocal chromosomal translocations frequently cause gene fusions involving the lysine (K)‐specific methyltransferase 2A gene ( KMT2A , also known as MLL ). Specific KMT2A fusion partners are associated with the disease phenotype (lymphoblastic vs. myeloid), and the type of KMT2A rearrangement also has prognostic implications. However, the KMT2A partner gene cannot always be identified by banding karyotyping. We sought to identify such partner genes in 13 cases of childhood leukemia with uninformative karyotypes by combining molecular techniques, including multicolor banding FISH, reverse‐transcriptase PCR, and long‐distance inverse PCR. Of the KMT2A fusion partner genes, MLLT3 was present in five patients, all with acute lymphoblastic leukemia, MLLT1 in two patients, and MLLT10 , MLLT4 , MLLT11 , and AFF1 in one patient each. Reciprocal reading by long‐distance inverse PCR also disclosed KMT2A fusions with PITPNA in one patient, with LOC100132273 in another patient, and with DNA sequences not compatible with any gene in three patients. The most common KMT2A breakpoint region was intron/exon 9 (3/8 patients), followed by intron/exon 11 and 10. Finally, multicolor banding revealed breakpoints in other chromosomes whose biological and prognostic implications remain to be determined. We conclude that the combination of molecular techniques used in this study can efficiently identify KMT2A fusion partners in complex pediatric acute leukemia karyotypes. Copyright © 2016 John Wiley & Sons, Ltd.